Cite
HARVARD Citation
Karnes, J. et al. (2021). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update. Clinical pharmacology & therapeutics. 109 (2), pp. 302-309. [Online].